Stockscreener 앱 받기
1.664
1.54%
-0.026
시간 외 거래:
1.65
-0.014
-0.84%
전일 마감가:
$1.69
열려 있는:
$1.7
하루 거래량:
83,543
Relative Volume:
0.95
시가총액:
$7.01M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.1309
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
-1.54%
1개월 성능:
+24.18%
6개월 성능:
-21.14%
1년 성능:
-55.52%
1일 변동 폭
$1.65
$1.70
1주일 범위
$1.60
$1.82
52주 변동 폭
$0.952
$6.39
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
1.664 | 7.12M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
What drives Tharimmune Inc. stock priceConsistently profitable trades - Autocar Professional
What analysts say about Tharimmune Inc. stockExtraordinary earning power - Autocar Professional
Is Tharimmune Inc. a good long term investmentPhenomenal trading returns - Autocar Professional
Tharimmune Inc. Stock Analysis and ForecastMassive stock growth - jammulinksnews.com
Will Tharimmune Inc. stock split in the near futureQuick Profit Idea Stream - Newser
What risks could impact Tharimmune Inc. stock performanceRisk Managed Trading Strategy - Newser
What makes Tharimmune Inc. stock price move sharplyFree Trading Strategy Suggestions - Newser
How Tharimmune Inc. stock performs during market volatilityElite Stock Shortlist - Newser
Why Tharimmune Inc. stock attracts strong analyst attentionFree Stock Trading Community - Newser
Tharimmune CEO Appajosyula buys shares worth $90,972 - Investing.com
Tharimmune Announces $2.5M Private Placement Agreement - TipRanks
Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors - The Holland Sentinel
EON Resources Inc. Announcement - Worcester Telegram
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street - Lubbock Avalanche-Journal
Tharimmune announces key leadership changes to advance pipeline - Investing.com
Navy SEAL Commander Joins Biotech Developing Military Defense Against Weaponized Fentanyl - Stock Titan
Don Kim Resigns as CFO of Tharimmune effective immediatelySEC filing - MarketScreener
Interactive Strength Inc. (Nasdaq:TRNR) Closes Initial $55 Million Investment for Crypto Treasury Strategy and Begins Acquiring $FET - Lohud
Hawley Crescent Catering & Events Wins 2025 Consumer Choice Award for Catering Excellence in Durham Region - Cincinnati Enquirer
Tharimmune announces executive changes and new agreements - Investing.com Australia
Tharimmune announces executive changes and new agreements By Investing.com - Investing.com Nigeria
TharimmuneRandy Milby Resigns As CEO And Board Member - marketscreener.com
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025 - IndyStar
Tharimmune Holds Annual Meeting, Elects Directors - TipRanks
Tharimmune (THAR) Appoints Strategic Advisor to Enhance TH104 De - GuruFocus
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback - Jonesboro Sun
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):